Insurance for unexpected expenses in case of complications during treatment and 48 months after treatment Coverage up to 200,000 USD


Dr.Rafet Eren (Hematologist)– Best Costs, Reviews – Book Your Consultation
Prof. Dr. Rafet Eren, MD, PhD is a senior hematologist at Biruni University Hospital in Istanbul, Turkey. He has approximately 18 years of specialized experience in the diagnosis and treatment of blood disorders.
- Around 18 years of experience in hematology
- Expert in leukemia (acute and chronic), lymphoma, multiple myeloma, myeloproliferative diseases, anemia, hemophilia, thalassemia, immune thrombocytopenia
- Offers bone marrow transplantation, CAR T‑cell therapy, stem cell procedures and biological therapies
- Fluent in English, regularly treats and consults with international patients
Educational Background
- MD, Istanbul University Faculty of Medicine, 2007
- Specialist in Internal Medicine, Marmara University Faculty of Medicine, 2012
- PhD in Hematology, Istanbul Training and Research Hospital, 2018
- Associate Professor in Hematology, Prof. Dr. Cemil Taşçıoğlu Training and Research Hospital, 2019
Professional Experience
- Associate Professor in Hematology, Biruni University Hospital since 2023
- Previous appointments include Istanbul University Cerrahpaşa (General Surgery and Internal Medicine), Marmara University, Prof. Dr. Cemil Taşçıoğlu Hospital, Başakşehir Çam and Sakura City Hospital, Bozyaka Training and Research Hospital, Istinye University / Liv Hospital between 2007‑2023
- Approximately 50 peer‑reviewed publications in national and international journals
Academic Contributions
- Speaker at national and international hematology conferences
- Research topics include prognostic markers in ITP, neutrophil‑lymphocyte ratio significance, polycythemia vera quality-of-life assessments
- Published recent case report on hypocellular acute myeloid leukemia in Turk J Haematol
Areas of Expertise
- Leukemias (acute and chronic), lymphoma, multiple myeloma
- Bone marrow transplantation and cellular therapies (CAR T‑cell, haploidentical transplants)
- Management of bleeding and clotting disorders—hemophilia, immune thrombocytopenia
- Supportive care for anemia, thalassemia, myeloproliferative syndromes
- Monitoring and treating chemotherapy and treatment side-effects
Publications and Research
Prof. Dr. Eren has authored numerous studies focusing on hematologic disorders and biomarkers, including:
- Research on neutrophil‑lymphocyte ratio as a prognostic factor in immune thrombocytopenia patients
- A study assessing quality of life in polycythemia vera patients with Biruni University team
- Case report on hypocellular acute myeloid leukemia published in Turk J Haematol, May 2025
Patient Care Philosophy
- Committed to clear communication and patient education at every stage of treatment
- Personalizes therapy plans based on the latest scientific evidence
- Focuses on compassionate care, symptom management, and holistic outcomes
- Offers telemedicine consultations for international patients with fluent English support
Professional Affiliations
- Associate Professor, Hematology Department, Biruni University Hospital
- Member of Turkish Society of Hematology, Hematology Specialty Society, European Society of Hematology
- Winner of Young Researcher Award at the 42nd Turkish Hematology Congress (2016)
FAQs
- Is Dr. Rafet Eren board‑certified?
- Yes. He is certified in Internal Medicine with subspecialty training in Hematology and holds the title of Associate Professor.
- What blood disorders does he treat?
- He treats a wide range including leukemia, lymphoma, multiple myeloma, anemia, hemophilia, thalassemia, myeloproliferative diseases, and immune thrombocytopenia.
- Does he perform bone marrow transplants?
- Yes, he provides allogeneic bone marrow transplantation, CAR T‑cell therapy, and related cellular therapies.
- Does he treat international patients?
- Yes, Dr. Eren offers English‑language care and teleconsultations for international patients.
- How many publications does he have?
- Around 50 peer‑reviewed publications in Turkish and international hematology journals.
- How does he approach patient care?
- He emphasizes clear treatment planning, symptom relief, and patient education, using the latest evidence-based protocols.
- What advanced topics has he researched?
- He has explored prognostic blood markers like neutrophil‑lymphocyte ratio, quality‑of‑life in polycythemia vera, and rare leukemia case reports.
Patient reviews
Patient reviews









